Sweden, Finland and the UK shut down child transition over safety concerns
Robby Starbuck said:
“Multiple countries from Sweden to Finland to The UK have now rolled back or shut down child transition treatments over safety concerns.”
Three named countries with strong healthcare reputations all moving in the same direction sounds like a convergent scientific consensus, and the phrase "safety concerns" implies the evidence base itself has been found wanting.
Sweden and Finland moved puberty blocker prescribing into research settings, which means young people can still access them under study protocols rather than through routine clinical referral. The UK closed the Tavistock's Gender Identity Development Service and replaced it with regional hubs, a service-delivery restructuring rather than a finding that the treatments are harmful. These are distinct national policy decisions, made in different political and healthcare contexts, not a shared scientific verdict, and the WPATH Standards of Care 8, published after most of these decisions, continues to recommend gender-affirming care including hormones for adolescents. When the phrase 'safety concerns' is used to cover all of this, the families who pay the price are those in countries where care remains available, who are now frightened away from treatment by a consensus that does not exist.
Families and young people in countries that have not restricted care are misled into believing an international scientific consensus against treatment exists, which it does not.